Barbara G. Wells, Pharm.D., Dean
Paul S. Cady, Ph.D., Interim Associate Dean
Chair and Associate Professor Culbertson
Professors Hurley, Sharp
Associate Professors Adamcik, Bartlomè, Beckwith, Gould, Mason, Rhodes
Clinical Associate Professors Jue
Assistant Professors Cady, Cook, Erramouspe, Force, Hefflinger, Larson, Madaras-Kelly, Matsuyama, Reitz
Clinical Assistant Professor Sawyer
Visiting Clinical Assistant Professors Heyneman, Phelan
Chair and Professor Diedrich
Professors Dodson, Fontenelle, Goettsch, Isaacson
Associate Professors Daniels, Jarvi, LaHann, Lai, Nelson, Torian
Assistant Professors Mobley, Ratka
Affiliate Professors Senekowitsch, Vestal, Wilson
Visiting Instructors Hubit, Kale
Affiliate Associate Professors Olson, Stevens
Affiliate Assistant Professors Charan, Cusack, Nielson, Ramagopal
The College of Pharmacy offers two graduate degrees: the Master of Science (M.S.) in Pharmacy and the Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences. The College also offers a professional doctorate degree, Doctor of Pharmacy (Pharm.D.). The Pharm.D. is described in the College of Pharmacy section of the University Bulletin.
Master of Science in Pharmacy
The M.S. program offers the student a choice of five majors:
1. Major in Pharmaceutical Chemistry leading to the degree of M.S. in Pharmacy (Pharmaceutical Chemistry)
2. Major in Pharmacognosy leading to the degree of M.S. in Pharmacy (Pharmacognosy)
3. Major in Pharmacology leading to the degree of M.S. in Pharmacy (Pharmacology)
4. Major in Pharmaceutics leading to the degree of M.S. in Pharmacy (Pharmaceutics)
5. Major in Pharmacy Administration leading to the degree of M.S. in Pharmacy (Pharmacy Administration)
To qualify for admission, a student must possess a professional degree in pharmacy (B.S. or Pharm.D.), or a baccalaureate degree in chemistry, biology, or a related field from an accredited institution, and have a grade point average of 3.0 or better over the last two years of undergraduate study. Students with a grade point average between 2.75 and 3.0 will receive consideration for admission on a conditional basis.
Following the award of the professional degree, students would be changed to classified status.
All applicants are required to provide three letters of recommendation from professors from whom they have taken courses or under whose direction they have worked. It is highly recommended that the Graduate Record Examination be taken prior to the start of the semester in which a student begins graduate study. The GRE must be taken during the first semester in residence if it has not been taken previously.
All candidates are required to demonstrate a reading knowledge of a foreign language or proficiency with a research tool (such as computer programming and/or statistics). Individual requirements for each student must be approved by the student's major professor within the emphasis area.
All classified graduate students must register for the appropriate graduate seminar (601) each semester in which they are registered for graduate credit. A maximum of four credits in graduate seminar (601) may be applied toward the degree.
Professional students currently enrolled in the College of Pharmacy may be granted early admission to a graduate program administered by the College following completion of the second professional (P2) year in the Pharm.D. curriculum.
In order that a student be eligible for early admission to a graduate program in the College, the following criteria must be met:
1. Completion of at least 136 academic credits must be certified to the Graduate Dean by the Registrar. Such certification must include all University general education requirements; and all College of Pharmacy pre-pharmacy, first (P1) and second (P2) professional year course requirements in the Pharm.D. curriculum.
2. Minimum Graduate Record Examination scores: For admission to the M.S. program, attainment of scores on the GRE at the 35th percentile or better in either the verbal or quantitative portion of the test. For admission to the Ph.D. program, attainment of scores on the GRE at the 50th percentile
3. Formal application for admission to the College graduate program, with acceptance as a conditional student by the appropriate department faculty.
After meeting the above three criteria, a student may be admitted to the Graduate School on a conditional basis. Following the award of the Pharm.D. degree, the student may petition to change to classified status. Students should consult the Graduate School Bulletin for course requirements for the graduate degrees offered by the College.
Candidates must complete the following courses:
PSCI 601 Graduate Seminar 2 cr PSCI 603 Scientific Writing 2 cr PSCI 605 Principles of Instrumental Techniques 3 cr PSCI 606 Selected Techniques in the Laboratory 2 cr PSCI 607 Research Foundations in the Pharmaceutical Sciences 2 cr total PSCI 650 Thesis Research 6 cr minimum
Graduate School requirement is a minimum of 30 credits including at least 6 credit hours in thesis research (PSCI 650). For all degree candidates, at least one half of total graduate credit hours required by the student's Graduate Program Committee must be 600 level. Minimum graduate credit requirements usually do not fulfill Departmental degree requirements.
Candidates may elect either a thesis or non-thesis option and must complete the following courses:
NON-THESIS THESIS STATISTICS AND RESEARCH METHODS BIOS 605 Biometry 4 cr OR PPRA 518 Clinical Research Design and Analysis 4 cr PADM 605 Research Methods 3 cr 3 cr PHARMACY ADMINISTRATION MAJOR COURSES PADM 601 Graduate Seminar in Pharmacy Administration 2 cr 2 cr PADM 610 Social and Behavioral Aspects of Pharmacy Practice 3 cr 3 cr OR PADM 632 Medical Economics 3 cr 3 cr PADM 634 Advanced Pharmacy Aministration I 3 cr 3 cr OR PADM 635 Advanced Pharmacy Administration II 3 cr 3 cr `Major area elective courses 15 cr 12 cr Total 12 cr RESEARCH ACTIVITY PADM 650 Thesis Research 6 cr PADM 651 Master's Paper 3 cr Total 33 cr 33 cr
Candidates must complete the following courses while enrolled in the P3 and P4 years of the Pharm.D. curriculum. (The courses listed below substitute for PSCI 532 Clinical Research Design and Analysis, and 6 credits of professional electives required in the Pharm.D. curriculum). In addition, the following courses taken in the P3 year will constitute a minor area in Clinical Pharmacy as required in the graduate program: PPRA 534 and PPRA 535 Therapeutics I and II, PSCI 529 Clinical Pharmacokinetics, and PSCI 568 Toxicology; PPRA 569 will substitute for 3 cr. of PADM 650 Thesis Research.
BIOS 605 Biometry 4 cr OR MBA 602 Survey of Business Statistical Techniques 3 cr PADM 605 Research Methods in Pharmacy Administration 3 cr OR MBA 630 Business Research 3 cr Pharmacy Administration 3 cr Major Area Graduate Course
PPRA 569 Clinical Research Clerkship 4 cr
PADM 601 Graduate Seminar 2 cr Major Area Courses 12 cr PADM 650 Thesis Research 3 cr Total 17 cr Ph.D.: PADM 601 Graduate Seminar 4 cr Multivariate Analysis 4 cr Research Methods Elective 3 cr Major Area Courses 21 cr PSCI 698 Dissertation Research 18 cr PSCI 699 Dissertation Prep 1 cr Total 51 cr
Doctor of Philosophy
Programs of study leading to the Doctor of Philosophy (Ph.D.) degree are offered through the Department of Pharmaceutical Sciences (emphasis areas of Pharmacology, Pharmacokinetics, Biopharmaceutics, and Biopharmaceutical Analysis) and through the Department of Pharmacy Practice and Administrative Sciences (emphasis in Pharmacy Administration). The Ph.D. degree is a research degree and will be conferred upon the completion and report of a substantial body of original work.
1. Professional degree in pharmacy or a baccalaureate degree in a related field with a GPA of not less than 3.0 for the final two years;
2. Achieve at least the 50th percentile in two of the Graduate Record Examination aptitude section scores (Verbal, Quantitative or Analytical). Requirements may differ within the College of Pharmacy's two Departments; check with the Department for specific requirements; and
3. Three letters of recommendation.
Students not meeting the minimum admission requirements for the Ph.D. program may reapply to continue on for the Ph.D. degree following successful completion of the M.S. in Pharmaceutical Sciences program.
Each beginning graduate student will have a graduate advisor/program committee assigned from the graduate faculty upon entry into the program. The student's advisor/graduate program committee will assist the student in preparing an appropriate program of study of course work. While there is no fixed credit requirement for the Ph.D. in Pharmaceutical Sciences, the overall program of study will include at least 72 semester hours of graduate course work. The student is expected to have selected a major advisor from the graduate faculty no later than the end of his/her third semester in residence.
A grade below B is unsatisfactory and will not be counted toward fulfilling the minimum requirements for the degree. Upon recommendation of the student's advisor/graduate program committee and with the approval of the Head of the Graduate Program, a student may be required to withdraw at any time for failure to maintain satisfactory progress toward the degree.
When course work is essentially complete candidates for the Ph.D. degree complete a series of written and oral comprehensive examinations which may include the defense of a written research proposal. Upon completion of all proposed research, the student's findings will be reported in the form of a dissertation to be prepared in accordance with Department and Graduate School guidelines. While the dissertation must be defended to the graduate faculty of the College, acceptability only requires the affirmative vote of a majority of the student's committee members.
Doctor of Philosophy in Pharmaceutical Sciences (Pharmacology, Pharmacokinetics,
Biopharmaceutics, and Biopharmaceutical Analysis Emphasis)
Candidate must complete the following courses:
PSCI 601 Graduate Seminar in Pharmaceutical Sciences 4 cr PSCI 603 Scientific Writing 2 cr PSCI 605 Principles of Instrumental Techniques 3 cr PSCI 606 Selected Techniques in the Laboratory 2 cr PSCI 607 Research Foundations in the Pharmaceutical Sciences 4 cr PSCI 698 Dissertation Research 18 cr* min. PSCI 699 Dissertation 1-2 cr* min.
*Candidates may only count PSCI 698 and 699 credits earned after admission to candidacy toward completion of degree requirements. A minimum of 20 units in combination must be completed.
A minimum of 72 credits including a minimum of 20 credit hours in dissertation research (PSCI 698) and dissertation (PSCI 699) completed following admission to candidacy are required. For all degree candidates, at least one half of total graduate credit hours required by the student's Graduate Program Committee must be 600 level. Minimum graduate credit requirements usually do not fulfill Departmental degree requirements.
Doctor of Philosophy in Pharmaceutical Sciences
(Pharmacy Administration Emphasis)
Candidates must complete the following courses:
BIOS 605 Biometry 4 cr Multivariate Analysis 4 cr PADM 605 Research Methods 3 cr One additional methods course (e.g. 3 cr MBA 630, SOC 508, PSYC 632) 3 cr
PADM 601 Graduate Seminar in Pharmacy Administration 4 cr PADM 610 Social and Behavior Aspects of Pharmacy Practice 3 cr PADM 632 Medical Economics 3 cr PADM 634 Advanced Pharmacy Administration I 3 cr PADM 635 Advanced Pharmacy Administration II 3 cr Major area elective courses 12 cr
Minor area elective courses 12 cr
PADM 650 Thesis Research** 3 cr PSCI 698 Dissertation Research 18 cr PSCI 699 Dissertation Preparation 1 cr Total 73-76 cr
*A student entering the Ph.D. program with a M.S. degree in a related area may petition the Advisory Committee to waive the elective 12 credits required in a minor area of study.
**All students must have research experience prior to beginning the dissertation. If a student has not completed a M.S. thesis, then s/he must complete a minimum of 3 credits of graduate research (PADM 650) and complete a research project resulting in a paper of publishable quality. If a student has completed a M.S. thesis, s/he may petition the Advisory Committee to accept it as fulfillment of this requirement.
Revised: May 1, 1996